1-2 of 2
Keywords: T1a prostate cancer
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Active Surveillance for Incidental (cT1a/b) Prostate Cancer: Long-Term Outcomes of the Prospective Noninterventional HAROW Study

Available to Purchase
Subject Area:
Further Areas
Jan Herden, Andreas Schwarte, Edith A. Boedefeld, Lothar Weissbach
Journal: Urologia Internationalis
Urol Int (2021) 105 (5-6): 428–435.
https://doi.org/10.1159/000512893
Published Online: 29 January 2021
..., instructions or products referred to in the content or advertisements. HAROW study Active surveillance Incidental prostate cancer Health-service research T1a prostate cancer T1b prostate cancer Incidental prostate cancer (IPC) is a tumor diagnosed after surgical treatment for benign prostate...
View article titled, Active Surveillance for Incidental (cT1a/b) Prostate Cancer: Long-Term Outcomes of the Prospective Noninterventional HAROW Study
Open the PDF for Active Surveillance for Incidental (cT1a/b) Prostate Cancer: Long-Term Outcomes of the Prospective Noninterventional HAROW Study in another window
Journal Articles

Treatment of Incidental Prostate Cancer by Active Surveillance: Results of the HAROW Study

Available to Purchase
Subject Area:
Further Areas
Jan Herden, Okyaz Eminaga, Sebastian Wille, Lothar Weissbach
Journal: Urologia Internationalis
Urol Int (2015) 95 (2): 209–215.
https://doi.org/10.1159/000431024
Published Online: 30 May 2015
... T1a prostate cancer T1b prostate cancer Prostate cancer (PCa) is termed ‘incidental' if diagnosed by transurethral resection of the prostate (TURP) or suprapubic prostatectomy. These interventions are indicated in cases of bladder outlet obstruction, for instance due to benign prostatic...
View article titled, Treatment of Incidental Prostate Cancer by Active Surveillance: Results of the HAROW Study
Open the PDF for Treatment of Incidental Prostate Cancer by Active Surveillance: Results of the HAROW Study in another window